PNEUMOCYSTIS JIROVECII INFECTION

Clinical trials for PNEUMOCYSTIS JIROVECII INFECTION explained in plain language.

Never miss a new study

Get alerted when new PNEUMOCYSTIS JIROVECII INFECTION trials appear

Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECII INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

Could a lower dose of a common drug fight pneumonia with fewer side effects?

Disease control Recruiting now

This study is testing if a lower dose of the standard antibiotic treatment for Pneumocystis pneumonia (PCP) works as well as the current higher dose but causes fewer serious side effects. It will enroll over 400 immunocompromised adults with PCP. The goal is to find a safer, equa…

Matched conditions: PNEUMOCYSTIS JIROVECII INFECTION

Phase: PHASE3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PNEUMOCYSTIS JIROVECII INFECTION

Get alerted when new PNEUMOCYSTIS JIROVECII INFECTION trials appear

Could a lower dose of a common drug fight pneumonia with fewer side effects?